BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33541320)

  • 1. Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.
    Berkovitch G; Cohen S; Lubetzky R; Singer D; Yerushalmy-Feler A
    BMC Pediatr; 2021 Feb; 21(1):63. PubMed ID: 33541320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
    Yerushalmy-Feler A; Olbjorn C; Kolho KL; Aloi M; Musto F; Martin-de-Carpi J; Lozano-Ruf A; Yogev D; Matar M; Scarallo L; Bramuzzo M; de Ridder L; Kang B; Norden C; Wilson DC; Tzivinikos C; Turner D; Cohen S
    Inflamm Bowel Dis; 2024 Feb; 30(2):159-166. PubMed ID: 37042978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for poor outcome of hospitalized children with inflammatory bowel disease.
    Yerushalmy-Feler A; Singer D; Berkovitch G; Lubetzky R; Dotan I; Ziv-Baran T; Cohen S
    Eur J Pediatr; 2020 Jan; 179(1):157-164. PubMed ID: 31709474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
    Nguyen NH; Luo J; Paul P; Kim J; Syal G; Ha C; Rudrapatna V; Park S; Parekh N; Zheng K; Sauk JS; Limketkai B; Fleshner P; Eisenstein S; Ramamoorthy S; Melmed G; Dulai PS; Boland BS; Mahadevan U; Sandborn WJ; Ohno-Machado L; McGovern D; Singh S
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):173-181.e5. PubMed ID: 35644340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy.
    Ardizzone S; Ferretti F; Monico MC; Carvalhas Gabrielli AM; Carmagnola S; Bezzio C; Saibeni S; Bosani M; Caprioli F; Mazza S; Casini V; Cortelezzi CC; Parravicini M; Cassinotti A; Cosimo P; Indriolo A; Di Sabatino A; Lenti MV; Pastorelli L; Conforti F; Ricci C; Sarzi-Puttini P; Vecchi M; Maconi G
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3050-3055. PubMed ID: 34159648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis.
    Takeuchi M; Tomomasa T; Yasunaga H; Horiguchi H; Fushimi K
    Pediatr Int; 2015 Jun; 57(3):443-8. PubMed ID: 25442802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
    Ko MK; Ng SC; Mak LY; Li MK; Lo FH; Ng CK; Lao WC; Tsang S; Chan KH; Hui YT; Shan EH; Loo CK; Hui AJ; To WP; Hung IF; Leung WK
    J Dig Dis; 2016 Sep; 17(9):610-617. PubMed ID: 27533786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
    Breton J; Kastl A; Hoffmann N; Rogers R; Grossman AB; Mamula P; Kelsen JR; Baldassano RN; Albenberg L
    Inflamm Bowel Dis; 2019 Aug; 25(9):1586-1593. PubMed ID: 30715364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment With Biologic Agents Has Not Reduced Surgeries Among Patients With Crohn's Disease With Short Bowel Syndrome.
    Limketkai BN; Parian AM; Chen PH; Colombel JF
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1908-1914.e2. PubMed ID: 28666947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization for Varicella and Zoster in Children with Inflammatory Bowel Disease.
    Adams DJ; Nylund CM
    J Pediatr; 2016 Apr; 171():140-5. PubMed ID: 26826886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing rate of a positive family history of inflammatory bowel disease (IBD) in pediatric IBD patients.
    Ruban M; Slavick A; Amir A; Ben-Tov A; Moran-Lev H; Weintraub Y; Anafy A; Cohen S; Yerushalmy-Feler A
    Eur J Pediatr; 2022 Feb; 181(2):745-751. PubMed ID: 34568966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
    Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy: A Multicenter Experience from Romania.
    Pavel C; Diculescu M; Constantinescu G; Plotogea OM; Sandru V; Meianu C; Dina I; Pop I; Butuc A; Mihaila M; Stan-Ilie M
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837538
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study.
    Law CC; Sasidharan S; Rodrigues R; Nguyen DD; Sauk J; Garber J; Giallourakis C; Xavier R; Khalili H; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2016 Sep; 22(9):2149-57. PubMed ID: 27482978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Nguyen GC; Murthy SK; Bressler B; Lam MCW; Alali A; Toumi A; Reinglas J; Rampersad A; Weizman AV; Afif W;
    Inflamm Bowel Dis; 2017 May; 23(5):695-701. PubMed ID: 28426451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis.
    Palacio FGM; de Souza LMP; Moreira JPL; Luiz RR; de Souza HSP; Zaltman C
    BMC Gastroenterol; 2021 Apr; 21(1):192. PubMed ID: 33906627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007).
    Benchimol EI; Guttmann A; To T; Rabeneck L; Griffiths AM
    Inflamm Bowel Dis; 2011 Oct; 17(10):2153-61. PubMed ID: 21910177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.